Skip to main content

Table 2 Portal vein embolization (PVE): outcome measures

From: Transcatheter embolization with Squid, combined with other embolic agents or alone, in different abdominal diseases: a single-center experience in 30 patients

Patients Gender Age Disease Segments FLR-V pre (mL) FLR-V post (mL) Increase FLR-V % TELV pre (Ml) TELV post (mL) Embolized lobe-V pre (mL) Embolized lobe-V post (mL) FLR-V/
TELV pre (%)
FLR-V/
TELV post (%)
Increase FLR-V/TELV (%) ASTpre (UI/L) ALTpre (UI/L) Bilipre (mg/dL) ASTpost (UI/L) ALTpost (UI/L) Bilipost (mg/dL) TL-F (%/min/m2) FLR-F (%/min/m2)
1 F 79 MTS RPVE+IVb 273.4 518.7 89.72% 1331.6 1230.3 1058.2 711.6 20.53% 42.16% 105.34% 51 0.52 71 61 0.72 0.72 / /
2 M 77 Cholangio RPVE 405.8 647.9 59.66% 1462.4 1846.1 1056.6 1198.2 27.75% 35.10% 26.48% 28 29 1.15 30 40 0.74 / /
3 M 74 Cholangio RPVE 413.8 707.6 71.00% 1439 1520.4 1025.2 812.8 28.76% 46.54% 61.85% 165 171 7.42 66 78 3.72 / /
4 F 70 MTS RPVE+IV 245.5 371.2 51.20% 1230.6 1137.1 985.1 765.9 19.95% 32.64% 63.63% 262 111 1.55 201 55 4.52 2.2 1.55
5 M 79 HCC RPVE 640.7 751.7 17.32% 1453.5 1313.7 812.8 562 44.08% 57.22% 29.81% 76 118 1.02 52 71 0.7 6.58 4.95
6 F 56 MTS RPVE+IV 647.8 813 25.50% 1461.7 1332.8 813.9 519.8 44.32% 61.00% 37.64% 164 435 0.51 73 235 0.6 5.15 4.1
7 M 55 Cholangio RPVE+I + IV 360.3 504.4 39.99% 1402.3 1340.1 1042 835.7 25.69% 37.64% 46.49% 21 52 0.56 16 32 0.25 5.96 2.52
8 M 78 MTS RPVE+I + IV 325.6 464.5 42.66% 1374.1 1492.9 1048.5 1028.4 23.70% 31.11% 31.31% 41 66 0.4 26 27 0.9 5.47 0.44
9 M 77 HCC RPVE 675.4 1099.9 62.85% 1556.5 1857.1 881.1 757.2 43.39% 59.23% 36.49% 92 44 0.75 106 52 1.07 4.39 2.07
10 F 55 Cholangio RPVE+IV 356.4 610 71.16% 1471.1 1750 1114.7 1140 24.23% 34.86% 43.88% 94 77 1.32 23 15 10.74 6.92 3.23
  1. ALT Alanino Aminotransferase, AST Aspartate Aminotransferase, Bili bilirubine, CRC-MTS colo-rectal cancer metastases, HCC hepatocellular carcinoma, FLR-V future liver remnant volume, FLR-F future liver remnant function, TELV total estimated liver volume, TL-F total liver function